March 26, 2024 March 26, 2024Categories New TrialsNow Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutationThis study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
July 19, 2023 July 19, 2023Categories Editorials7 ways advocates have enhanced ECOG-ACRIN’s cancer research programECOG-ACRIN’s cancer research advocates recently reflected on their committee’s key accomplishments
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapyThis study is for patients with solid tumors that are progressing after treatment with taxane therapies
March 23, 2023 March 23, 2023Categories New TrialsThe ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinationsHospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months